AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery
Clinical trial NCT03965494 · TERMINATED
Trial details
- NCT number
- NCT03965494
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-02
- Primary completion
- 2023-10-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.